Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 29 of 29 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/24
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 09/11/24
End: 01/20/25
Due: 01/20/26
Phase: N/A
Priority: Normal
Start: 03/25/23
End: 04/28/23
Due: 04/28/24
Phase: N/A
Priority: Normal
Start: 12/07/19
End: 05/18/20
Due: 05/18/21
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Pharmacokinetics，Safety and Efficacy of ZSP1273 in Children 2-17 Years Old With Influenza A | NCT06656026 | Guangdong Raynovent Biotech Co., Ltd | user2@example.com | None | 2024-11-30 | 2025-12-31 | 2026-12-31 | - | - | 2025-07-14 |
| A Study of RAY1225 in Participants With Impaired Kidney Function | NCT06613763 | Guangdong Raynovent Biotech Co., Ltd | user2@example.com | None | 2024-09-11 | 2025-01-20 | 2026-01-20 | - | - | 2025-07-14 |
| Mass Balance Study of [14C]ZSP1273 in Healthy Adult Male Subjects in China | NCT05873426 | Guangdong Raynovent Biotech Co., Ltd | user2@example.com | None | 2023-03-25 | 2023-04-28 | 2024-04-28 | - | - | 2025-07-14 |
| Study of ZSP1273 in Patients With Acute Uncomplicated Influenza A | NCT04024137 | Guangdong Raynovent Biotech Co., Ltd | user2@example.com | None | 2019-12-07 | 2020-05-18 | 2021-05-18 | - | - | 2025-07-14 |